Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Online Portals: ‘Critical’ Doors To Boost Consumer OTC Literacy, Drive Sales

This article was originally published in The Tan Sheet

Executive Summary

OTC firms should use online portals to provide details on OTC products and health conditions they treat, says health care services consultant Tim Covington. I\information currently available online is fragmented and fails to communicate the financial benefit of OTCs over unnecessary doctor’s visits, he says.

You may also be interested in...



Manufacturing, Advertising Coalition Tackles Digital Ad-Block Devastation

P&G and Unilever work with Google and advertising experts worldwide to form the Coalition for Better Ads aiming for new online advertising standards. The coalition has not yet determined whether Google would provide better placement for ads complying with the standards.

Manufacturing, Advertising Coalition Tackles Digital Ad-Block Devastation

P&G and Unilever work with Google and advertising experts worldwide to form the Coalition for Better Ads aiming for new online advertising standards. The coalition has not yet determined whether Google would provide better placement for ads complying with the standards.

Social Media Guidance Gives Drug Firms A Pass On User Content

The draft guidance outlines substantial reporting requirements for websites that firms control and for content on third-party sites – as well as saying when FDA intends to use enforcement discretion.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS107596

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel